This is a prospective, observational and exploratory clinical study. The object of this study is to evaluate the accuracy of a novel serological risk model on blood samples in early diagnosis of cholangiocarcinoma patients.
A reliable and accurate preoperative tool capable of early diagnosing malignant cholangiocarcinoma is lacking and urgently needed for clinical practice. This study proposes to establish and evaluate a novel serological risk model on blood samples for non-invasively diagnosing cholangiocarcinoma. The study includes the construction of capable novel serological risk model and the validation of the diagnosis model.
Study Type
OBSERVATIONAL
Enrollment
60
No interventions
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Guangzhou, Guangdong, China
Malignant/Benign status of enrolled suspected cholangiocarcinoma patients by pathological examination
The pathological examination results of each enrolled patient will be recorded
Time frame: 4 weeks
Malignant/Benign status of enrolled suspected cholangiocarcinoma patients evaluated by the novel serological risk model
The novel serological risk model will be constructed for differential malignant/benign diagnosis
Time frame: 2 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.